Oligoprogressive clinical trials

Explore recruiting oligoprogressive clinical trials.

Recruiting oligoprogressive studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oligoprogressive trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Metastasis-directed therapy in oligoprogressive castration-refractory prostate cancer: a randomized phase 3 trial

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Radiation during Osimertinib Treatment: a Safety and Efficacy Cohort Study (ROSE)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A modular, first time in human, open label, multiple dose, accelerated escalation with cohort expansion study of the safety and pharmacokinetics of intravenous infusion of CP-506, a tumor agnostic Hypoxia Activated Prodrug in patients with HRD/FAD solid tumors or tumor types with high incidence of HRD/FAD in monotherapy or in combination with carboplatin or patients with solid tumor and oligoprogressive disease receiving immune checkpoint inhibitors (ICI): a phase I-IIa clinical trial.

Netherlands, Belgium, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Oligoprogressive trials by city

Oligoprogressive in Toronto Oligoprogressive in Vancouver Oligoprogressive in Montreal Oligoprogressive in Calgary Oligoprogressive in Edmonton Oligoprogressive in Ottawa Oligoprogressive in Winnipeg Oligoprogressive in Quebec City Oligoprogressive in Hamilton Oligoprogressive in Kitchener Oligoprogressive in London Oligoprogressive in Halifax Oligoprogressive in New York Oligoprogressive in Los Angeles Oligoprogressive in Chicago Oligoprogressive in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease